RFP For GLP-1 Medication Access, Affordability & Management Solutions

The City of Cambridge is soliciting proposals under solicitation number COC-RFP-FY27-31207 for GLP-1 Medication Access, Affordability and Management Solutions. The city seeks a direct-to-employer passthrough or subsidy model that allows approximately 800 members to purchase GLP-1 medications through discounted cash-pay pharmacy channels or manufacturer direct-purchase programs without integrating these medications into the city's existing medical or pharmacy benefits. The selected contractor must be a licensed pharmacy or pharmacy services organization authorized to operate in Massachusetts and maintain documented sourcing arrangements with Eli Lilly's LillyDirect and Novo Nordisk's NovoCare Pharmacy programs. Proposals are due by 11:00 am on October 15, 2026, via the electronic procurement portal. The contract requires a strict implementation timeline, with member onboarding beginning by March 1, 2027, and prescription filling active by April 1, 2027. Key performance metrics include a target median turnaround time of fewer than five business days from request to receipt of medication. Awarding will be based on the most advantageous proposal, considering quality requirements, composite ratings, and the ability to provide aggregate reporting on utilization and spend. Contractors must adhere to HIPAA regulations, provide a Business Associate Agreement, and comply with the Cambridge Living Wage Ordinance and the Truck Safety Ordinance for contracts exceeding 10,000 dollars annually. All deliveries must be made in original manufacturer packaging as inside deliveries to the city's destination.